Result of AGM

RNS Number : 1689G

Allergy Therapeutics PLC

18 November 2015

 



18 November 2015

Allergy Therapeutics plc

("Allergy Therapeutics" or the 'Company")

Result of Annual General Meeting

Allergy Therapeutics, the fully integrated specialty pharmaceutical company specialising in allergy vaccines, announces that at the Annual General Meeting held today, all the resolutions put to that meeting were duly passed.

For further information:

Allergy Therapeutics	[phone]
Manuel Llobet, Chief Executive Officer
Ian Postlethwaite, Finance Director
Panmure Gordon	[phone]
Freddy Crossley / Peter Steel / Duncan Monteith, Corporate Finance
Tom Salvesen, Corporate Broking
FTI Consulting	[phone]
Simon Conway / Mo Noonan / Victoria Foster Mitchell

Note to editors:

About Allergy Therapeutics

Allergy Therapeutics is a specialty pharmaceutical company focused on allergy vaccination.  It has a growing business achieving revenue in the last financial year of £43 million mainly in Europe through its own sales and marketing infrastructure and further afield through distributors.

 

END

 

 

RAGFFEFEAFISEEF